Overview

Paracetamol for Cancer Pain

Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Randomised, double-blind placebo controlled cross-over trial Main goal: Optimize the medical pain treatment for patients with advanced cancer disease Study goal: Measure paracetamol's additional analgesic effect in a situation where the patient is concomitantly treated with oral opioids eqv. morphine > 100 mg/d.
Phase:
Phase 4
Details
Lead Sponsor:
Haraldsplass Deaconess Hospital
Treatments:
Acetaminophen